3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Liver Metastases
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Lobular
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
9
X-Rays
8
Specimen Handling
8
Phantoms, Imaging
7
fludarabine
6
Magnetic Resonance Spectroscopy
6
cabozantinib
5
Gemcitabine
5
Biopsy
5
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Doxorubicin
4
fludarabine phosphate
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
irinotecan sucrosofate
2
ensartinib
2
atezolizumab
2
Vincristine
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Positron Emission Tomography Computed Tomography
×
90 days
×
Clear all
No trials found.